Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alexion
Pharma
AZ to pull bleeding reversal agent after FDA flags risk imbalance
Andexxa is slated to be pulled from the market in the coming days. The FDA said it "considers the risks of the product to outweigh its benefits."
Eric Sagonowsky
Dec 19, 2025 1:12pm
Novartis sues AZ's Alexion over 'misleading' Ultomiris marketing
Oct 22, 2025 1:19pm
AZ's Alexion spotlights gMG for next awareness-raising film
Jul 31, 2025 12:42pm
AZ touts Ultomiris results in post-transplant complication trial
Jun 16, 2025 10:32am
Syntimmune shareholders win again over AZ, this time for $181M
Jun 12, 2025 11:40am
Health plan sues AZ's Alexion over 'fraudulent' Soliris patents
Apr 17, 2025 10:50am
